SPYRAL DYSTAL Renal Denervation Global Clinical Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 128 participants.

Also called NCT04311086

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 128 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04311086
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Germany, Greece, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04311086. Allocation not applicable; no masking; primary purpose treatment. Start 2020-06-12 (actual); primary completion 2022-12-22 (actual). Results posted on 2024-04-17.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
SPYRAL DYSTAL Renal Denervation Global Clinical Study
Condition
Hypertension
Condition
Vascular Diseases
Condition
Cardiovascular Diseases
Intervention (Device)
Renal Denervation (Symplicity Spyral™)
Lead sponsor
Medtronic Vascular (class: industry)

Record details

Record id
cardio:ct-nct04311086
Content hash
fc6a9820d67a3e0da8e926dff316bd6250000f2148f87ec55bfe6c4930edfd87